Site icon YCNews

Japanese Media: Japanese Pharmaceutical Company Psoriasis Drug Mixed with Sleep Inducer, Killing One

Japanese Media: Japanese Pharmaceutical Company Psoriasis Drug Mixed with Sleep Inducer, Killing One

kyodo

According to Japan’s Kyodo News Agency on the 12th, a patient prescribed for the drug died on the 10th due to the mixing of sleep inducer ingredients in the psoriatic drug “Itraconazole Tablet 50’MEEK'”, a pharmaceutical company in Fukui Prefecture, Japan.

Fukui Prefecture Government also said that 133 symptoms such as loss of consciousness and memory loss occurred.

Kobayashi Chemical said that it had locked in 364 people who had been prescribed and contacted everyone to ask for a stop. According to the Fukui County Government, “Kolayashi Chemical Industry” reported the side effects of the drug, and 133 symptoms such as loss of consciousness and memory loss appeared.

Among them, 34 cases were confirmed to be hospitalized (including discharge). There were 16 driving accidents involving cars suspected to have been affected by drugs.

The prefecture government also revealed that the prescribed patients were scattered in 31 prefectures, the largest number of 58 in Osaka Prefecture, followed by 57 in Tokushima Prefecture and 49 in Gifu Prefecture.

According to the report, the deceased was a woman in her 70s who was hospitalized in Capital Circle Hospital.

According to the report, in the operation of adding some batches of raw materials, the person in charge mistaken the main ingredient and sleep inducer “Limaza seal hydrochloride hydrate”. The manufacturing process has not been approved by the Ministry of Health, Labour and Welfare.

“Xiaolin Chemical” revealed that it was confirmed that there was a situation of unconsciousness soon after taking it and was rushed to the hospital; there was also a situation where consciousness disappeared while driving and crashed into the central isolation belt.

According to the report, someone took medicine again after leaving the hospital, and the symptoms were repeated.

According to the report, Kobayashi Chemical said that he took this matter very seriously and apologized again sincerely for the death of the patient. The report revealed that the patient took the drug with the lot number “T0EG08”.

Hiroyuki Kobayashi, the president of the company, apologized in an interview on the 12th, saying, “I am deeply responsible for committing a major mistake.”

Exit mobile version